242.05
price up icon0.18%   0.4975
 
loading
Precedente Chiudi:
$241.55
Aprire:
$242.52
Volume 24 ore:
145.95K
Relative Volume:
0.15
Capitalizzazione di mercato:
$35.52B
Reddito:
$4.81B
Utile/perdita netta:
$1.11B
Rapporto P/E:
39.29
EPS:
6.16
Flusso di cassa netto:
$1.35B
1 W Prestazione:
+4.56%
1M Prestazione:
+0.80%
6M Prestazione:
+10.86%
1 anno Prestazione:
+58.65%
Intervallo 1D:
Value
$240.69
$242.75
Intervallo di 1 settimana:
Value
$231.17
$242.75
Portata 52W:
Value
$151.95
$260.49

Resmed Inc Stock (RMD) Company Profile

Name
Nome
Resmed Inc
Name
Telefono
(858) 746-2400
Name
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Name
Dipendente
10,140
Name
Cinguettio
@resmed
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
RMD's Discussions on Twitter

Confronta RMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
RMD 242.10 35.52B 4.81B 1.11B 1.35B 6.16
ISRG 550.09 194.93B 7.87B 2.24B 586.00M 4.25
BDX 224.96 64.77B 20.18B 1.73B 3.07B 5.51
ALC 85.55 42.36B 9.76B 1.16B 665.00M 0.72
WST 317.70 22.75B 2.88B 499.60M 321.60M 7.41

Resmed Inc Stock (RMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-02-06 Ripresa KeyBanc Capital Markets Overweight
2023-10-27 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-10-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2023-10-09 Aggiornamento JP Morgan Neutral → Overweight
2023-09-29 Downgrade Wolfe Research Outperform → Peer Perform
2023-09-06 Aggiornamento Needham Hold → Buy
2023-09-05 Downgrade UBS Buy → Neutral
2023-08-01 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-05-23 Iniziato UBS Buy
2023-04-14 Iniziato Mizuho Buy
2023-01-17 Aggiornamento JP Morgan Neutral → Overweight
2022-10-28 Downgrade Citigroup Buy → Neutral
2022-10-20 Aggiornamento BofA Securities Neutral → Buy
2022-10-12 Iniziato Jefferies Hold
2022-09-08 Aggiornamento Citigroup Neutral → Buy
2022-08-15 Downgrade CLSA Buy → Outperform
2022-08-12 Downgrade Citigroup Buy → Neutral
2022-08-12 Downgrade JP Morgan Overweight → Neutral
2022-08-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-06-06 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2022-04-06 Iniziato Wolfe Research Outperform
2022-01-31 Aggiornamento Citigroup Neutral → Buy
2022-01-31 Aggiornamento Goldman Neutral → Buy
2022-01-28 Aggiornamento RBC Capital Mkts Underperform → Sector Perform
2022-01-24 Aggiornamento BofA Securities Underperform → Neutral
2022-01-24 Aggiornamento JP Morgan Neutral → Overweight
2022-01-13 Aggiornamento CLSA Outperform → Buy
2022-01-13 Aggiornamento Robert W. Baird Neutral → Outperform
2021-12-21 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2021-12-06 Aggiornamento Macquarie Neutral → Outperform
2021-10-22 Aggiornamento CLSA Underperform → Outperform
2021-08-02 Downgrade CLSA Outperform → Sell
2021-08-02 Downgrade Needham Buy → Hold
2021-07-28 Aggiornamento Jefferies Underperform → Hold
2021-07-26 Downgrade JP Morgan Overweight → Neutral
2021-07-14 Iniziato RBC Capital Mkts Underperform
2021-06-28 Downgrade Citigroup Buy → Neutral
2021-06-22 Aggiornamento Macquarie Neutral → Outperform
2021-06-22 Iniziato Robert W. Baird Neutral
2021-06-21 Reiterato Needham Buy
2021-06-16 Downgrade BofA Securities Neutral → Underperform
2021-06-09 Aggiornamento CLSA Sell → Outperform
2021-05-21 Aggiornamento JP Morgan Neutral → Overweight
2021-05-11 Aggiornamento Citigroup Neutral → Buy
2021-04-30 Downgrade Citigroup Buy → Neutral
2021-03-16 Aggiornamento Needham Hold → Buy
2020-11-02 Aggiornamento UBS Neutral → Buy
2020-10-30 Aggiornamento JP Morgan Underweight → Neutral
2020-10-27 Aggiornamento BofA Securities Underperform → Neutral
2020-08-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-06-17 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-05-01 Downgrade JP Morgan Neutral → Underweight
2020-05-01 Aggiornamento Oppenheimer Perform → Outperform
2020-02-18 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-02-03 Iniziato CLSA Underperform
2020-01-31 Downgrade UBS Buy → Neutral
2020-01-10 Iniziato Oppenheimer Perform
2019-11-22 Iniziato KeyBanc Capital Markets Sector Weight
2019-07-29 Aggiornamento UBS Neutral → Buy
2019-07-16 Downgrade UBS Buy → Neutral
2019-05-06 Aggiornamento UBS Neutral → Buy
2019-04-18 Aggiornamento JP Morgan Underweight → Neutral
2019-01-25 Downgrade Goldman Buy → Neutral
2019-01-25 Downgrade JP Morgan Neutral → Underweight
2018-10-26 Aggiornamento Credit Suisse Neutral → Outperform
2018-07-02 Iniziato Goldman Buy
Mostra tutto

Resmed Inc Borsa (RMD) Ultime notizie

pulisher
06:30 AM

Resmed Inc Announces Upcoming Stock Sale - MSN

06:30 AM
pulisher
06:01 AM

ResMed Inc. Officer Plans Major Stock Sale - MSN

06:01 AM
pulisher
04:37 AM

Caprock Group LLC Acquires 2,806 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat

04:37 AM
pulisher
04:12 AM

ResMed Inc. (NYSE:RMD) Shares Acquired by Natixis Advisors LLC - MarketBeat

04:12 AM
pulisher
04:12 AM

ResMed Inc. (NYSE:RMD) Shares Acquired by Empowered Funds LLC - MarketBeat

04:12 AM
pulisher
Nov 20, 2024

ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

ResMed Inc. stock rises Wednesday, outperforms market - MarketWatch

Nov 20, 2024
pulisher
Nov 20, 2024

3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD) - Yahoo Finance

Nov 20, 2024
pulisher
Nov 20, 2024

3,041 Shares in ResMed Inc. (NYSE:RMD) Acquired by Retireful LLC - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Meeder Asset Management Inc. Buys 3,174 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

3 ASX shares Australians can buy and hold for the next decade - MSN

Nov 19, 2024
pulisher
Nov 19, 2024

ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch

Nov 19, 2024
pulisher
Nov 19, 2024

Second Half Financial Partners LLC Takes Position in ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

LGT Capital Partners LTD. Decreases Stake in ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

LMR Partners LLP Sells 18,741 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Top broker says buy ResMed and this ASX 200 share - MSN

Nov 18, 2024
pulisher
Nov 18, 2024

Publication relating to transparency notifications, Business Wires News - AsiaOne

Nov 18, 2024
pulisher
Nov 18, 2024

Nyxoah’s Voting Rights Shift with ResMed Stake - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

Publication relating to transparency notifications - The Manila Times

Nov 18, 2024
pulisher
Nov 18, 2024

ResMed's Stake in Nyxoah Drops Below 5% Threshold in Latest Holdings Update | NYXH Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 18, 2024

ResMed Inc. (NYSE:RMD) Shares Acquired by Mawer Investment Management Ltd. - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders - Yahoo Finance

Nov 18, 2024
pulisher
Nov 18, 2024

Victory Capital Management Inc. Has $28.49 Million Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

ResMed (ASX:RMD) 3-Year EBITDA Growth Rate : 11.10% (As of Sep. 2024) - GuruFocus.com

Nov 18, 2024
pulisher
Nov 16, 2024

KBC Group NV Increases Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

ResMed Inc. stock rises Friday, outperforms market - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

What is Zacks Research's Forecast for ResMed Q1 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Sumitomo Mitsui Trust Group Inc. Increases Position in ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

ResMed Inc. stock falls Thursday, underperforms market - MarketWatch

Nov 14, 2024
pulisher
Nov 14, 2024

Insider Sale: Director Witte De Sells Shares of ResMed Inc (RMD) - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

ResMed director Jan De Witte sells shares worth $198,052 - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

ResMed Inc Insider Sells Shares, Retains Ownership - MSN

Nov 14, 2024
pulisher
Nov 14, 2024

What is Zacks Research's Forecast for ResMed Q2 Earnings? - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Insiders At ResMed Sold US$16m In Stock, Alluding To Potential Weakness - Yahoo Finance Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Baillie Gifford & Co. Lowers Stake in ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Versor Investments LP Sells 2,400 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

ResMed CFO Brett Sandercock sells $249,000 in stock - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch

Nov 13, 2024
pulisher
Nov 13, 2024

OVERSEA CHINESE BANKING Corp Ltd Has $4.75 Million Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Entropy Technologies LP Invests $1.87 Million in ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why - Simply Wall St

Nov 13, 2024
pulisher
Nov 12, 2024

ResMed’s Peter Farrell Adjusts Stock Holdings - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

ResMed Inc Director Adjusts Stock Holdings - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

ResMed’s Executive Stock Transactions Highlight Compensation Practices - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

ResMed Inc. CEO Executes Strategic Stock Transactions - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

ResMed Inc’s Executive Share Transactions Revealed - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

ResMed CFO Sandercock Sells 1,000 Shares - TipRanks

Nov 12, 2024
pulisher
Nov 11, 2024

ResMed Updates Dividend Details for ASX CDI Holders - TipRanks

Nov 11, 2024
pulisher
Nov 11, 2024

Zacks.com featured highlights include Greenbrier, Walmart, Leidos, InterDigital and ResMed - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

ResMed Inc. (NYSE:RMD) Shares Bought by Principal Financial Group Inc. - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Los Angeles Capital Management LLC Lowers Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat

Nov 10, 2024

Resmed Inc Azioni (RMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_instruments_supplies ALC
$85.60
price up icon 0.08%
medical_instruments_supplies WST
$316.62
price up icon 1.63%
medical_instruments_supplies COO
$99.47
price up icon 0.42%
$77.65
price down icon 0.41%
$225.97
price up icon 0.71%
Capitalizzazione:     |  Volume (24 ore):